维普中文期刊产品整合服务
98篇 您的检索式:作者名="Meredith PA"
    题名 作者 年代 出处 被引量
1Optimal dosing characteristics of the angiotensin II receptor antagonist telmisartan显示文摘Meredith PA 1999Am J Cardiol1999,84,2:1
2Dihydropyridine calcium channel blockers:basic pharmacological similarities but fundamental therapeutic differences显示文摘 Elliott HL 2004J Hypertens2004,22,:1
3Trough:peak ratio:Clinically useful or practically irrelevant显示文摘Elliott HL Meredith PA 1995J Hypertens1995,13,3:1
4Pharmacodynamic modeling of the antihypertensive response to amlodipine显示文摘Donnelly R Meredith PA Miller SH 1993Clin Pharmacol Ther1993,54,3:1
5Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure:Assessment of Reduction in Mortality and Morbidity) Program显示文摘Meredith PA Ostergren J Anand I 2008J Am Coll Cardiol2008,52,24:1
6Pars plana vitrectomy for severe penetrat-injury with posterior segmenting volvement显示文摘Meredith TA Gordon PA 1987Am J Ophthalmol1987,103,:1
7Pars plana vitrectomy for severe penetrating injury withposterior segment involvement显示文摘Meredith TA Cordon PA 1987Am J Ophthalmol1987,103,5:1
8Trough: peak ratio and smoothness index for antihypenenaive agents显示文摘Meredith PA 1999Blood Press Monit1999,4,5:1
9The interactions between felodipine and two beta- adrenoceptor antagonists:atenolol and propranolol 显示文摘Elliott HL Meredith PA Mcnally C 1991Br J Clin Pharmacol1991,32,3:1
10Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade:further analysis of the 'ACTION' database in patients with angina显示文摘Elliott HL Meredith PA 2011J Hum Hypertens2011,25,:1
11Trough:peak ratio:clinically useful or practically irrelevant?显示文摘Elliott HL Meredith PA 1995Hypertens1995,13,3:1
12Optimal dosing characteristics of the angiotensin Ⅱ receptor antagonist telmisartan 显示文摘Meredith PA 1999Am J Cardiol1999,84,2:1
13Craniofacial resection at the University of Virginia (1976-1992) : survival analysis显示文摘Levine PA Debo RF Meredith SD 1994Head Neck1994,16,6:1
14Blood pvessure Vanriabbililty and its Complications for anti-hypertensive the rapy显示文摘Meredith PA 0,,:1
15Trough:peak ratio and smoothness index for antihypertensive agents显示文摘Meredith PA 1999Blood Press Monit1999,4,5:1
16Dihydropyridine calcium channel blockers: basic pharmacological similarities but fundamental therapeutic differ- ences 显示文摘Meredith PA Elliott HL 2004J Hypertens2004,22,9:1
17How to evaluate t he duration of blood pressure control : the trough : peak ratio and 24-hourmonitoring显示文摘Meredith PA 1998Cardiovasc Pharmacol1998,31,2:1
18FDA guidelines on trough:peak ratios in the evalu ation ofantihypertensive agents 显示文摘MEREDITH PA ELLIOTT HL 1994J Cardiovasc Pharmacol1994,235,:1
19How to evaluate the duration of blood pressure control: The trough: peak ratio and 24 - hour monitoring显示文摘Meredith PA 1998Cardiovasc Pharmacol1998,31,2:1
20Pars plana vitrectiomy for severe perforating ocular injury with posterior segment involvement 显示文摘Meredith TA Gordon PA 1987Am J Ophthalmol1987,103,3:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费